Clinical Staging Tools for the Impacts of Obesity on Individuals

Overview

This study will assess various published staging tools to assess the health impacts of obesity on individuals. The aim is to identify benefits and drawbacks, and thus help Obesity Centres and GPs better assess obese individuals as well as better identify who benefits most from having weight loss treatment.

Full Title of Study: “Assessing Clinical Staging Tools for Tracking the Impacts of Obesity on Individuals”

Study Type

• Study Type: Observational
• Study Design
  • Time Perspective: Prospective
• Study Primary Completion Date: August 2011

Detailed Description

This study will assess various published staging tools to assess the health impacts of obesity on individuals. The aim is to identify benefits and drawbacks, and thus help Obesity Centres and GPs better assess obese individuals as well as better identify who benefits most from having weight loss treatment

Interventions

• Procedure: Bariatric surgery
  • Bariatric surgery: Gastric bypass, Sleeve gastrectomy, or Gastric banding

Arms, Groups and Cohorts

• Obese patients
  • Obese patients for Bariatric surgery

Clinical Trial Outcome Measures

Primary Measures

• Changes in Obesity Scores After Weight Loss Treatment
  • Time Frame: Minimum of 1 year follow-up
  • Changes were measured in the following clinical domains -Airway, Body Mass Index, Cardiovascular risk, Diabetes, Economic, Functional. Gonadal, Body Image. An improvement was considered when any 1 of these domains changes for the positive. Thus, if a patient had an improvement in cardiovascular risk the intervention was considered beneficial even if no other domains changed. Out measure is calculated as the count of participants achieving at least 1 improvement (Count)

Secondary Measures

• Changes in Obesity Scores in Various Subgroups
  • Time Frame: Minimum of 1 year follow-up
  • Changes in obesity scores in patients with carious co-morbid conditions (eg, type 2 diabetes, sleep apnoea) before bariatric surgery

Participating in This Clinical Trial

Inclusion Criteria

• Morbid obesity – At least 1 year follow-up after bariatric surgery Exclusion Criteria:

• N/A

Gender Eligibility: All

Minimum Age: 16 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

• Lead Sponsor
  • Imperial College London
• Provider of Information About this Clinical Study
  • Sponsor
• Overall Official(s)
  • Carek le Roux, MD PhD, Study Chair, Imperial College London